Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Michael G. Gartside
Based on 9 articles published since 2009
(Why 9 articles?)
||||
Expertise Level
The expertise of Michael G. Gartside ranks in the
  • Top 1.8%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 9 articles on the topic.
Graphical view (beta)
Aliases Gartside, Michael G   ·   Gartside, Michael
Work Locations
Details
Most likely:    QIMR Berghofer Medical Research Institute      
2017
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · CNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France. · Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 28759004
2015
  • QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. · Institut für Humangenetik, Medizinische Universität Graz, Harrachgasse 21, 8010, Graz, Austria. · QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Molecular and Population Genetics Laboratory and Genomic Medicine Theme Oxford NIHR Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK. · Pubmed 26251183
  • QIMR Berghofer Medical Research Institute,Brisbane,Queensland,Australia. · Pubmed 25787093
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2014
  • Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Molecular Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Statistical Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 24686849
2013
  • Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Pubmed 23890154
2011
  • Queensland Institute of Medical Research, Brisbane, Queensland, Australia. · Pubmed 22197930
Probable:    Translational Genomics Research Institute      
2009
  • Division of Cancer and Cell Biology, Translational Genomics Research Institute, Phoenix, AZ 85004, USA. · Pubmed 19147536
Possible:    Harvard University Boston   Contact    
2011
  • Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts 02114, USA. · Pubmed 22080950
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Michael G. Gartside in 2009-2019 about Melanoma:

  • A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF. 2017
  • POLE mutations in families predisposed to cutaneous melanoma. 2015
  • Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases. 2015
  • Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. 2015
  • POT1 loss-of-function variants predispose to familial melanoma. 2014
  • Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. 2013
  • Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. 2011
  • A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. 2011
  • Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. 2009
Show List of Full Article Records
Google Searches

Learn more about Michael G. Gartside using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
QIMR Berghofer Medical Research Institute
Translational Genomics Research Institute
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
QIMR Berghofer Medical Research Institute
2017
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · CNRS UMR 9187, INSERM U1196, Institut Curie, PSL Research University and Université Paris Sud, Université Paris Saclay, Orsay, France. · Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Pubmed 28759004
2015
  • QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. · Institut für Humangenetik, Medizinische Universität Graz, Harrachgasse 21, 8010, Graz, Austria. · QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Molecular and Population Genetics Laboratory and Genomic Medicine Theme Oxford NIHR Biomedical Research Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. · Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK. · Pubmed 26251183
  • QIMR Berghofer Medical Research Institute,Brisbane,Queensland,Australia. · Pubmed 25787093
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2014
  • Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK. · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Molecular Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia. · Statistical Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK. · Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 24686849
2013
  • Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Pubmed 23890154
2011
  • Queensland Institute of Medical Research, Brisbane, Queensland, Australia. · Pubmed 22197930
Translational Genomics Research Institute
2009
  • Division of Cancer and Cell Biology, Translational Genomics Research Institute, Phoenix, AZ 85004, USA. · Pubmed 19147536
Harvard University Boston
2011
  • Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Massachusetts 02114, USA. · Pubmed 22080950
Yearly article counts 00103110201
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.